Hypothesis: a short nicotinamide riboside lead-in will unmask exercise responsiveness in seropositive rheumatoid arthritis by restoring mitophagy before telomere-driven T-cell exhaustion

In seropositive rheumatoid arthritis patients with low baseline activity and short leukocyte telomeres, a 2-week nicotinamide riboside lead-in followed by 8 weeks of eccentric resistance training will produce a larger fall in DNAm GrimAge and a larger rise in PBMC mitophagy markers than exercise alone. The effect should concentrate in the subgroup with the lowest baseline mitophagy score, because NAD+ restoration will be able to improve mitochondrial quality control before telomere-associated DNA damage locks T cells into a pro-inflammatory state. Test this in a randomized pilot with serial telomere length, NAD+/NADH ratio, PBMC mitophagy markers, CRP, and epigenetic clock deltas as co-primary endpoints.